nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP2A6—lung cancer	0.0864	0.272	CbGaD
Tamoxifen—ABCG2—lung cancer	0.0772	0.243	CbGaD
Tamoxifen—CYP2E1—lung cancer	0.0613	0.193	CbGaD
Tamoxifen—CYP1A1—lung cancer	0.0605	0.19	CbGaD
Tamoxifen—DHCR7—Doxorubicin—lung cancer	0.0409	0.0965	CbGbCtD
Tamoxifen—ABCB1—lung cancer	0.0321	0.101	CbGaD
Tamoxifen—CES1—Irinotecan—lung cancer	0.0206	0.0488	CbGbCtD
Tamoxifen—CYP1B1—Erlotinib—lung cancer	0.0131	0.031	CbGbCtD
Tamoxifen—ABCB11—Paclitaxel—lung cancer	0.012	0.0284	CbGbCtD
Tamoxifen—CYP1B1—Paclitaxel—lung cancer	0.012	0.0284	CbGbCtD
Tamoxifen—ABCG2—Topotecan—lung cancer	0.0115	0.0273	CbGbCtD
Tamoxifen—ABCG2—Gefitinib—lung cancer	0.0106	0.0249	CbGbCtD
Tamoxifen—ABCB11—Vinblastine—lung cancer	0.0105	0.0249	CbGbCtD
Tamoxifen—ABCG2—Teniposide—lung cancer	0.0102	0.0242	CbGbCtD
Tamoxifen—CYP1A1—Gefitinib—lung cancer	0.00975	0.023	CbGbCtD
Tamoxifen—CYP19A1—Paclitaxel—lung cancer	0.00975	0.023	CbGbCtD
Tamoxifen—CYP1B1—Docetaxel—lung cancer	0.00869	0.0205	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—lung cancer	0.00648	0.0153	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—lung cancer	0.00648	0.0153	CbGbCtD
Tamoxifen—ABCC2—Paclitaxel—lung cancer	0.00632	0.0149	CbGbCtD
Tamoxifen—ABCG2—Erlotinib—lung cancer	0.00624	0.0147	CbGbCtD
Tamoxifen—ABCC2—Irinotecan—lung cancer	0.00624	0.0147	CbGbCtD
Tamoxifen—CYP3A5—Gefitinib—lung cancer	0.00585	0.0138	CbGbCtD
Tamoxifen—CYP1A1—Erlotinib—lung cancer	0.00576	0.0136	CbGbCtD
Tamoxifen—ABCG2—Paclitaxel—lung cancer	0.00571	0.0135	CbGbCtD
Tamoxifen—CYP3A5—Teniposide—lung cancer	0.00567	0.0134	CbGbCtD
Tamoxifen—ABCG2—Irinotecan—lung cancer	0.00564	0.0133	CbGbCtD
Tamoxifen—ABCC2—Vinblastine—lung cancer	0.00554	0.0131	CbGbCtD
Tamoxifen—ABCC2—Cisplatin—lung cancer	0.00508	0.012	CbGbCtD
Tamoxifen—ABCC2—Etoposide—lung cancer	0.00499	0.0118	CbGbCtD
Tamoxifen—CYP2C19—Gefitinib—lung cancer	0.00472	0.0111	CbGbCtD
Tamoxifen—ABCG2—Cisplatin—lung cancer	0.0046	0.0109	CbGbCtD
Tamoxifen—CYP2C19—Teniposide—lung cancer	0.00458	0.0108	CbGbCtD
Tamoxifen—ABCC2—Docetaxel—lung cancer	0.00457	0.0108	CbGbCtD
Tamoxifen—ABCG2—Etoposide—lung cancer	0.00452	0.0107	CbGbCtD
Tamoxifen—CYP3A7—Paclitaxel—lung cancer	0.00422	0.00997	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00422	0.00997	CbGbCtD
Tamoxifen—CYP3A7—Irinotecan—lung cancer	0.00416	0.00983	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00416	0.00983	CbGbCtD
Tamoxifen—ABCB1—Topotecan—lung cancer	0.00416	0.00983	CbGbCtD
Tamoxifen—ABCG2—Docetaxel—lung cancer	0.00413	0.00976	CbGbCtD
Tamoxifen—CYP2B6—Irinotecan—lung cancer	0.00397	0.00936	CbGbCtD
Tamoxifen—CYP2C9—Gefitinib—lung cancer	0.00392	0.00926	CbGbCtD
Tamoxifen—ABCB1—Gefitinib—lung cancer	0.00381	0.00899	CbGbCtD
Tamoxifen—CYP2C9—Teniposide—lung cancer	0.0038	0.00898	CbGbCtD
Tamoxifen—CYP2D6—Gefitinib—lung cancer	0.00359	0.00847	CbGbCtD
Tamoxifen—CYP3A5—Crizotinib—lung cancer	0.00359	0.00847	CbGbCtD
Tamoxifen—CYP3A5—Erlotinib—lung cancer	0.00346	0.00817	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—lung cancer	0.00341	0.00804	CbGbCtD
Tamoxifen—CYP2C8—Erlotinib—lung cancer	0.00333	0.00785	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—lung cancer	0.0033	0.00779	CbGbCtD
Tamoxifen—CYP2B6—Cisplatin—lung cancer	0.00323	0.00763	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—lung cancer	0.00322	0.0076	CbGbCtD
Tamoxifen—CYP3A5—Paclitaxel—lung cancer	0.00317	0.00748	CbGbCtD
Tamoxifen—CYP3A5—Irinotecan—lung cancer	0.00312	0.00738	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—lung cancer	0.00308	0.00727	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00305	0.00721	CbGbCtD
Tamoxifen—CYP3A7—Docetaxel—lung cancer	0.00305	0.00721	CbGbCtD
Tamoxifen—CYP2C8—Paclitaxel—lung cancer	0.00304	0.00719	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—lung cancer	0.00298	0.00705	CbGbCtD
Tamoxifen—ABCB1—Vinorelbine—lung cancer	0.00293	0.00693	CbGbCtD
Tamoxifen—CYP2D6—Vinorelbine—lung cancer	0.00276	0.00653	CbGbCtD
Tamoxifen—CYP1A2—Erlotinib—lung cancer	0.00257	0.00608	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—lung cancer	0.0025	0.00591	CbGbCtD
Tamoxifen—CYP3A4—Topotecan—lung cancer	0.00249	0.00589	CbGbCtD
Tamoxifen—CYP2C8—Etoposide—lung cancer	0.00241	0.00568	CbGbCtD
Tamoxifen—ABCB1—Crizotinib—lung cancer	0.00233	0.00551	CbGbCtD
Tamoxifen—CYP3A5—Docetaxel—lung cancer	0.00229	0.00541	CbGbCtD
Tamoxifen—CYP3A4—Gefitinib—lung cancer	0.00228	0.00539	CbGbCtD
Tamoxifen—ABCB1—Gemcitabine—lung cancer	0.00228	0.00539	CbGbCtD
Tamoxifen—ABCB1—Erlotinib—lung cancer	0.00225	0.00532	CbGbCtD
Tamoxifen—CYP3A4—Teniposide—lung cancer	0.00221	0.00522	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—lung cancer	0.00217	0.00512	CbGbCtD
Tamoxifen—CYP2C9—Paclitaxel—lung cancer	0.00212	0.00501	CbGbCtD
Tamoxifen—CYP2D6—Erlotinib—lung cancer	0.00212	0.00501	CbGbCtD
Tamoxifen—ABCB1—Paclitaxel—lung cancer	0.00206	0.00487	CbGbCtD
Tamoxifen—ABCB1—Irinotecan—lung cancer	0.00203	0.0048	CbGbCtD
Tamoxifen—CYP1A2—Etoposide—lung cancer	0.00186	0.0044	CbGbCtD
Tamoxifen—ABCB1—Vinblastine—lung cancer	0.00181	0.00427	CbGbCtD
Tamoxifen—CYP3A4—Vinorelbine—lung cancer	0.00176	0.00415	CbGbCtD
Tamoxifen—CYP2C9—Cisplatin—lung cancer	0.00171	0.00403	CbGbCtD
Tamoxifen—CYP2D6—Vinblastine—lung cancer	0.0017	0.00402	CbGbCtD
Tamoxifen—ABCB1—Cisplatin—lung cancer	0.00166	0.00391	CbGbCtD
Tamoxifen—ABCB1—Etoposide—lung cancer	0.00163	0.00384	CbGbCtD
Tamoxifen—ABCB1—Docetaxel—lung cancer	0.00149	0.00352	CbGbCtD
Tamoxifen—EBPL—respiratory system—lung cancer	0.00149	0.0449	CbGeAlD
Tamoxifen—CYP3A4—Crizotinib—lung cancer	0.0014	0.0033	CbGbCtD
Tamoxifen—CYP3A4—Erlotinib—lung cancer	0.00135	0.00318	CbGbCtD
Tamoxifen—DHCR7—mammary gland—lung cancer	0.00126	0.038	CbGeAlD
Tamoxifen—FMO1—mammary gland—lung cancer	0.00126	0.038	CbGeAlD
Tamoxifen—EBPL—epithelium—lung cancer	0.00124	0.0375	CbGeAlD
Tamoxifen—CYP3A4—Paclitaxel—lung cancer	0.00123	0.00292	CbGbCtD
Tamoxifen—CYP3A4—Irinotecan—lung cancer	0.00122	0.00288	CbGbCtD
Tamoxifen—ABCB1—Doxorubicin—lung cancer	0.00111	0.00262	CbGbCtD
Tamoxifen—CYP3A4—Vinblastine—lung cancer	0.00108	0.00256	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—lung cancer	0.00108	0.00254	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—lung cancer	0.00105	0.00247	CbGbCtD
Tamoxifen—UGT1A4—respiratory system—lung cancer	0.00103	0.0311	CbGeAlD
Tamoxifen—CYP3A4—Etoposide—lung cancer	0.000976	0.0023	CbGbCtD
Tamoxifen—CYP3A4—Docetaxel—lung cancer	0.000893	0.00211	CbGbCtD
Tamoxifen—SULT1A1—trachea—lung cancer	0.000874	0.0263	CbGeAlD
Tamoxifen—ESRRA—respiratory system—lung cancer	0.000828	0.025	CbGeAlD
Tamoxifen—EBPL—lung—lung cancer	0.000791	0.0238	CbGeAlD
Tamoxifen—ESR2—mammary gland—lung cancer	0.000746	0.0225	CbGeAlD
Tamoxifen—FMO3—respiratory system—lung cancer	0.000727	0.0219	CbGeAlD
Tamoxifen—DHCR7—bronchus—lung cancer	0.000692	0.0209	CbGeAlD
Tamoxifen—ESRRA—bronchus—lung cancer	0.000682	0.0205	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—lung cancer	0.000665	0.00157	CbGbCtD
Tamoxifen—SULT1A1—lung—lung cancer	0.000628	0.0189	CbGeAlD
Tamoxifen—DHCR7—trachea—lung cancer	0.000622	0.0187	CbGeAlD
Tamoxifen—FMO1—trachea—lung cancer	0.000622	0.0187	CbGeAlD
Tamoxifen—ESRRA—trachea—lung cancer	0.000612	0.0184	CbGeAlD
Tamoxifen—FMO3—bronchus—lung cancer	0.000598	0.018	CbGeAlD
Tamoxifen—DHCR7—cardiac atrium—lung cancer	0.000584	0.0176	CbGeAlD
Tamoxifen—SIGMAR1—mammary gland—lung cancer	0.000578	0.0174	CbGeAlD
Tamoxifen—ESRRA—cardiac atrium—lung cancer	0.000575	0.0173	CbGeAlD
Tamoxifen—CES1—respiratory system—lung cancer	0.000574	0.0173	CbGeAlD
Tamoxifen—CYP1B1—mammary gland—lung cancer	0.00055	0.0166	CbGeAlD
Tamoxifen—EBPL—lymph node—lung cancer	0.000541	0.0163	CbGeAlD
Tamoxifen—ESR1—mammary gland—lung cancer	0.000511	0.0154	CbGeAlD
Tamoxifen—ESR2—respiratory system—lung cancer	0.000497	0.015	CbGeAlD
Tamoxifen—DHCR7—bone marrow—lung cancer	0.000493	0.0149	CbGeAlD
Tamoxifen—ESRRA—bone marrow—lung cancer	0.000485	0.0146	CbGeAlD
Tamoxifen—DHCR7—lung—lung cancer	0.000447	0.0135	CbGeAlD
Tamoxifen—FMO1—lung—lung cancer	0.000447	0.0135	CbGeAlD
Tamoxifen—ESRRA—lung—lung cancer	0.00044	0.0133	CbGeAlD
Tamoxifen—SULT1A1—lymph node—lung cancer	0.00043	0.0129	CbGeAlD
Tamoxifen—CYP2C8—mammary gland—lung cancer	0.000421	0.0127	CbGeAlD
Tamoxifen—ESR2—epithelium—lung cancer	0.000415	0.0125	CbGeAlD
Tamoxifen—Levomethadyl Acetate—CHRNB4—lung cancer	0.000407	0.171	CrCbGaD
Tamoxifen—EBP—Azacitidine—Gemcitabine—lung cancer	0.000391	1	CbGdCrCtD
Tamoxifen—FMO3—lung—lung cancer	0.000386	0.0116	CbGeAlD
Tamoxifen—CYP2C9—mammary gland—lung cancer	0.000374	0.0113	CbGeAlD
Tamoxifen—CYP1B1—respiratory system—lung cancer	0.000366	0.011	CbGeAlD
Tamoxifen—ESR1—respiratory system—lung cancer	0.00034	0.0103	CbGeAlD
Tamoxifen—SIGMAR1—bronchus—lung cancer	0.000317	0.00955	CbGeAlD
Tamoxifen—Loperamide—POMC—lung cancer	0.000306	0.129	CrCbGaD
Tamoxifen—DHCR7—lymph node—lung cancer	0.000306	0.00921	CbGeAlD
Tamoxifen—FMO1—lymph node—lung cancer	0.000306	0.00921	CbGeAlD
Tamoxifen—CES1—lung—lung cancer	0.000305	0.00919	CbGeAlD
Tamoxifen—ESRRA—lymph node—lung cancer	0.000301	0.00906	CbGeAlD
Tamoxifen—SIGMAR1—trachea—lung cancer	0.000285	0.00858	CbGeAlD
Tamoxifen—ESR1—epithelium—lung cancer	0.000285	0.00857	CbGeAlD
Tamoxifen—Levomethadyl Acetate—CHRNA3—lung cancer	0.000282	0.118	CrCbGaD
Tamoxifen—SIGMAR1—cardiac atrium—lung cancer	0.000267	0.00806	CbGeAlD
Tamoxifen—CYP2A6—lung—lung cancer	0.000265	0.00799	CbGeAlD
Tamoxifen—FMO3—lymph node—lung cancer	0.000264	0.00796	CbGeAlD
Tamoxifen—ESR2—lung—lung cancer	0.000264	0.00795	CbGeAlD
Tamoxifen—CYP1A2—respiratory system—lung cancer	0.000262	0.00791	CbGeAlD
Tamoxifen—CYP1A1—respiratory system—lung cancer	0.000259	0.0078	CbGeAlD
Tamoxifen—CYP3A5—respiratory system—lung cancer	0.000253	0.00763	CbGeAlD
Tamoxifen—CYP2B6—respiratory system—lung cancer	0.000252	0.00758	CbGeAlD
Tamoxifen—CYP2E1—respiratory system—lung cancer	0.000236	0.00712	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—lung cancer	0.000226	0.0068	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP2A6—lung cancer	0.000222	0.0934	CrCbGaD
Tamoxifen—CYP1A1—epithelium—lung cancer	0.000216	0.00652	CbGeAlD
Tamoxifen—CYP1A1—bronchus—lung cancer	0.000213	0.00642	CbGeAlD
Tamoxifen—CES1—lymph node—lung cancer	0.000209	0.00628	CbGeAlD
Tamoxifen—CYP2B6—bronchus—lung cancer	0.000207	0.00624	CbGeAlD
Tamoxifen—SIGMAR1—lung—lung cancer	0.000205	0.00616	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCG2—lung cancer	0.000199	0.0835	CrCbGaD
Tamoxifen—CYP1B1—lung—lung cancer	0.000194	0.00586	CbGeAlD
Tamoxifen—CYP1A1—trachea—lung cancer	0.000191	0.00577	CbGeAlD
Tamoxifen—ESR1—lung—lung cancer	0.000181	0.00545	CbGeAlD
Tamoxifen—ESR2—lymph node—lung cancer	0.000181	0.00544	CbGeAlD
Tamoxifen—CYP1A1—cardiac atrium—lung cancer	0.00018	0.00542	CbGeAlD
Tamoxifen—ABCG2—bone marrow—lung cancer	0.00016	0.00482	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP2E1—lung cancer	0.000158	0.0663	CrCbGaD
Tamoxifen—Clomifene—CYP2A6—lung cancer	0.000152	0.064	CrCbGaD
Tamoxifen—ABCG2—lung—lung cancer	0.000145	0.00436	CbGeAlD
Tamoxifen—CYP19A1—lymph node—lung cancer	0.000142	0.00429	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—lung cancer	0.00014	0.00422	CbGeAlD
Tamoxifen—CYP1A2—lung—lung cancer	0.000139	0.0042	CbGeAlD
Tamoxifen—CYP1A1—lung—lung cancer	0.000137	0.00414	CbGeAlD
Tamoxifen—ABCC2—lymph node—lung cancer	0.000136	0.00409	CbGeAlD
Tamoxifen—ABCB1—respiratory system—lung cancer	0.000134	0.00405	CbGeAlD
Tamoxifen—CYP3A5—lung—lung cancer	0.000134	0.00405	CbGeAlD
Tamoxifen—CYP2B6—lung—lung cancer	0.000134	0.00403	CbGeAlD
Tamoxifen—CYP1B1—lymph node—lung cancer	0.000133	0.00401	CbGeAlD
Tamoxifen—CYP2E1—lung—lung cancer	0.000125	0.00378	CbGeAlD
Tamoxifen—ESR1—lymph node—lung cancer	0.000124	0.00373	CbGeAlD
Tamoxifen—Toremifene—CYP1A1—lung cancer	0.000123	0.0519	CrCbGaD
Tamoxifen—ABCB1—epithelium—lung cancer	0.000112	0.00339	CbGeAlD
Tamoxifen—Clomifene—CYP2E1—lung cancer	0.000108	0.0454	CrCbGaD
Tamoxifen—Clomifene—CYP1A1—lung cancer	0.000107	0.0448	CrCbGaD
Tamoxifen—ABCB1—trachea—lung cancer	9.94e-05	0.00299	CbGeAlD
Tamoxifen—ABCG2—lymph node—lung cancer	9.9e-05	0.00298	CbGeAlD
Tamoxifen—CYP1A1—lymph node—lung cancer	9.4e-05	0.00283	CbGeAlD
Tamoxifen—Diethylstilbestrol—ABCB1—lung cancer	8.27e-05	0.0348	CrCbGaD
Tamoxifen—ABCB1—bone marrow—lung cancer	7.88e-05	0.00238	CbGeAlD
Tamoxifen—ABCB1—lung—lung cancer	7.14e-05	0.00215	CbGeAlD
Tamoxifen—Toremifene—ABCB1—lung cancer	6.56e-05	0.0276	CrCbGaD
Tamoxifen—Clomifene—ABCB1—lung cancer	5.67e-05	0.0238	CrCbGaD
Tamoxifen—ABCB1—lymph node—lung cancer	4.88e-05	0.00147	CbGeAlD
Tamoxifen—Orphenadrine—CYP2E1—lung cancer	4.86e-05	0.0204	CrCbGaD
Tamoxifen—Dry mouth—Paclitaxel—lung cancer	3.76e-05	0.000297	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—lung cancer	3.76e-05	0.000297	CcSEcCtD
Tamoxifen—Diarrhoea—Vinorelbine—lung cancer	3.75e-05	0.000296	CcSEcCtD
Tamoxifen—Dysgeusia—Docetaxel—lung cancer	3.75e-05	0.000296	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Cisplatin—lung cancer	3.74e-05	0.000295	CcSEcCtD
Tamoxifen—Infection—Etoposide—lung cancer	3.74e-05	0.000295	CcSEcCtD
Tamoxifen—Blood creatinine increased—Doxorubicin—lung cancer	3.72e-05	0.000293	CcSEcCtD
Tamoxifen—Back pain—Docetaxel—lung cancer	3.71e-05	0.000292	CcSEcCtD
Tamoxifen—Neutropenia—Methotrexate—lung cancer	3.71e-05	0.000292	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Irinotecan—lung cancer	3.7e-05	0.000292	CcSEcCtD
Tamoxifen—Oedema—Paclitaxel—lung cancer	3.69e-05	0.000291	CcSEcCtD
Tamoxifen—Paraesthesia—Cisplatin—lung cancer	3.69e-05	0.000291	CcSEcCtD
Tamoxifen—Thrombocytopenia—Etoposide—lung cancer	3.68e-05	0.000291	CcSEcCtD
Tamoxifen—Muscle spasms—Docetaxel—lung cancer	3.68e-05	0.000291	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—lung cancer	3.67e-05	0.000289	CcSEcCtD
Tamoxifen—Infection—Paclitaxel—lung cancer	3.67e-05	0.000289	CcSEcCtD
Tamoxifen—Dyspnoea—Cisplatin—lung cancer	3.66e-05	0.000289	CcSEcCtD
Tamoxifen—Erectile dysfunction—Methotrexate—lung cancer	3.65e-05	0.000288	CcSEcCtD
Tamoxifen—Loperamide—ABCB1—lung cancer	3.65e-05	0.0153	CrCbGaD
Tamoxifen—Hyperhidrosis—Etoposide—lung cancer	3.64e-05	0.000287	CcSEcCtD
Tamoxifen—Dizziness—Vinorelbine—lung cancer	3.63e-05	0.000286	CcSEcCtD
Tamoxifen—Thrombocytopenia—Paclitaxel—lung cancer	3.61e-05	0.000285	CcSEcCtD
Tamoxifen—Anorexia—Etoposide—lung cancer	3.59e-05	0.000283	CcSEcCtD
Tamoxifen—Abdominal pain—Irinotecan—lung cancer	3.58e-05	0.000282	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—lung cancer	3.58e-05	0.000282	CcSEcCtD
Tamoxifen—Decreased appetite—Cisplatin—lung cancer	3.57e-05	0.000282	CcSEcCtD
Tamoxifen—Hyperhidrosis—Paclitaxel—lung cancer	3.57e-05	0.000281	CcSEcCtD
Tamoxifen—Pneumonia—Methotrexate—lung cancer	3.56e-05	0.00028	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Cisplatin—lung cancer	3.55e-05	0.00028	CcSEcCtD
Tamoxifen—Anaemia—Docetaxel—lung cancer	3.54e-05	0.000279	CcSEcCtD
Tamoxifen—Depression—Methotrexate—lung cancer	3.52e-05	0.000278	CcSEcCtD
Tamoxifen—Anorexia—Paclitaxel—lung cancer	3.52e-05	0.000277	CcSEcCtD
Tamoxifen—Pain—Cisplatin—lung cancer	3.51e-05	0.000277	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Methotrexate—lung cancer	3.5e-05	0.000276	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—lung cancer	3.5e-05	0.000276	CcSEcCtD
Tamoxifen—Vomiting—Vinorelbine—lung cancer	3.49e-05	0.000275	CcSEcCtD
Tamoxifen—Rash—Vinorelbine—lung cancer	3.46e-05	0.000273	CcSEcCtD
Tamoxifen—Dermatitis—Vinorelbine—lung cancer	3.46e-05	0.000273	CcSEcCtD
Tamoxifen—Headache—Vinorelbine—lung cancer	3.44e-05	0.000271	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—lung cancer	3.43e-05	0.000271	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—lung cancer	3.43e-05	0.000271	CcSEcCtD
Tamoxifen—Leukopenia—Docetaxel—lung cancer	3.43e-05	0.000271	CcSEcCtD
Tamoxifen—Sweating—Methotrexate—lung cancer	3.39e-05	0.000267	CcSEcCtD
Tamoxifen—Paraesthesia—Etoposide—lung cancer	3.38e-05	0.000267	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—lung cancer	3.37e-05	0.000265	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Paclitaxel—lung cancer	3.36e-05	0.000265	CcSEcCtD
Tamoxifen—Dyspnoea—Etoposide—lung cancer	3.36e-05	0.000265	CcSEcCtD
Tamoxifen—Cough—Docetaxel—lung cancer	3.34e-05	0.000264	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—lung cancer	3.34e-05	0.000264	CcSEcCtD
Tamoxifen—Insomnia—Paclitaxel—lung cancer	3.34e-05	0.000263	CcSEcCtD
Tamoxifen—Hypersensitivity—Irinotecan—lung cancer	3.33e-05	0.000263	CcSEcCtD
Tamoxifen—Paraesthesia—Paclitaxel—lung cancer	3.31e-05	0.000261	CcSEcCtD
Tamoxifen—Hypertension—Docetaxel—lung cancer	3.31e-05	0.000261	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—lung cancer	3.3e-05	0.00026	CcSEcCtD
Tamoxifen—Dyspnoea—Paclitaxel—lung cancer	3.29e-05	0.000259	CcSEcCtD
Tamoxifen—Decreased appetite—Etoposide—lung cancer	3.27e-05	0.000258	CcSEcCtD
Tamoxifen—Arthralgia—Docetaxel—lung cancer	3.26e-05	0.000257	CcSEcCtD
Tamoxifen—Myalgia—Docetaxel—lung cancer	3.26e-05	0.000257	CcSEcCtD
Tamoxifen—Chest pain—Docetaxel—lung cancer	3.26e-05	0.000257	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—lung cancer	3.26e-05	0.000257	CcSEcCtD
Tamoxifen—Nausea—Vinorelbine—lung cancer	3.26e-05	0.000257	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Etoposide—lung cancer	3.25e-05	0.000256	CcSEcCtD
Tamoxifen—Dyspepsia—Paclitaxel—lung cancer	3.25e-05	0.000256	CcSEcCtD
Tamoxifen—Asthenia—Irinotecan—lung cancer	3.25e-05	0.000256	CcSEcCtD
Tamoxifen—Fatigue—Etoposide—lung cancer	3.24e-05	0.000256	CcSEcCtD
Tamoxifen—Constipation—Etoposide—lung cancer	3.22e-05	0.000254	CcSEcCtD
Tamoxifen—Pain—Etoposide—lung cancer	3.22e-05	0.000254	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—lung cancer	3.21e-05	0.000253	CcSEcCtD
Tamoxifen—Decreased appetite—Paclitaxel—lung cancer	3.21e-05	0.000253	CcSEcCtD
Tamoxifen—Dry mouth—Docetaxel—lung cancer	3.19e-05	0.000252	CcSEcCtD
Tamoxifen—Haemoglobin—Methotrexate—lung cancer	3.19e-05	0.000252	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Paclitaxel—lung cancer	3.19e-05	0.000251	CcSEcCtD
Tamoxifen—Fatigue—Paclitaxel—lung cancer	3.18e-05	0.000251	CcSEcCtD
Tamoxifen—Haemorrhage—Methotrexate—lung cancer	3.17e-05	0.00025	CcSEcCtD
Tamoxifen—Hepatitis—Methotrexate—lung cancer	3.17e-05	0.00025	CcSEcCtD
Tamoxifen—Asthenia—Gemcitabine—lung cancer	3.16e-05	0.000249	CcSEcCtD
Tamoxifen—Constipation—Paclitaxel—lung cancer	3.16e-05	0.000249	CcSEcCtD
Tamoxifen—Pain—Paclitaxel—lung cancer	3.16e-05	0.000249	CcSEcCtD
Tamoxifen—Pharyngitis—Methotrexate—lung cancer	3.15e-05	0.000248	CcSEcCtD
Tamoxifen—Oedema—Docetaxel—lung cancer	3.13e-05	0.000247	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—lung cancer	3.12e-05	0.000246	CcSEcCtD
Tamoxifen—Pruritus—Gemcitabine—lung cancer	3.12e-05	0.000246	CcSEcCtD
Tamoxifen—Infection—Docetaxel—lung cancer	3.11e-05	0.000245	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—lung cancer	3.11e-05	0.000245	CcSEcCtD
Tamoxifen—Diarrhoea—Irinotecan—lung cancer	3.1e-05	0.000244	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—lung cancer	3.08e-05	0.000243	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Etoposide—lung cancer	3.08e-05	0.000243	CcSEcCtD
Tamoxifen—Thrombocytopenia—Docetaxel—lung cancer	3.06e-05	0.000242	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—lung cancer	3.06e-05	0.000241	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.03e-05	0.000239	CcSEcCtD
Tamoxifen—Hypersensitivity—Cisplatin—lung cancer	3.03e-05	0.000239	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Paclitaxel—lung cancer	3.02e-05	0.000238	CcSEcCtD
Tamoxifen—Diarrhoea—Gemcitabine—lung cancer	3.02e-05	0.000238	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—lung cancer	3e-05	0.000237	CcSEcCtD
Tamoxifen—Dizziness—Irinotecan—lung cancer	2.99e-05	0.000236	CcSEcCtD
Tamoxifen—Urticaria—Etoposide—lung cancer	2.99e-05	0.000236	CcSEcCtD
Tamoxifen—Anorexia—Docetaxel—lung cancer	2.98e-05	0.000235	CcSEcCtD
Tamoxifen—Abdominal pain—Etoposide—lung cancer	2.98e-05	0.000235	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—lung cancer	2.98e-05	0.000235	CcSEcCtD
Tamoxifen—Asthenia—Cisplatin—lung cancer	2.95e-05	0.000232	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—lung cancer	2.93e-05	0.000231	CcSEcCtD
Tamoxifen—Urticaria—Paclitaxel—lung cancer	2.93e-05	0.000231	CcSEcCtD
Tamoxifen—Abdominal pain—Paclitaxel—lung cancer	2.92e-05	0.00023	CcSEcCtD
Tamoxifen—Vomiting—Irinotecan—lung cancer	2.88e-05	0.000227	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—lung cancer	2.87e-05	0.000226	CcSEcCtD
Tamoxifen—Rash—Irinotecan—lung cancer	2.85e-05	0.000225	CcSEcCtD
Tamoxifen—Dermatitis—Irinotecan—lung cancer	2.85e-05	0.000225	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Docetaxel—lung cancer	2.85e-05	0.000225	CcSEcCtD
Tamoxifen—Headache—Irinotecan—lung cancer	2.83e-05	0.000224	CcSEcCtD
Tamoxifen—Insomnia—Docetaxel—lung cancer	2.83e-05	0.000223	CcSEcCtD
Tamoxifen—Diarrhoea—Cisplatin—lung cancer	2.81e-05	0.000222	CcSEcCtD
Tamoxifen—Paraesthesia—Docetaxel—lung cancer	2.81e-05	0.000222	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—lung cancer	2.8e-05	0.000221	CcSEcCtD
Tamoxifen—Vomiting—Gemcitabine—lung cancer	2.8e-05	0.000221	CcSEcCtD
Tamoxifen—Dyspnoea—Docetaxel—lung cancer	2.79e-05	0.00022	CcSEcCtD
Tamoxifen—Rash—Gemcitabine—lung cancer	2.78e-05	0.000219	CcSEcCtD
Tamoxifen—Dermatitis—Gemcitabine—lung cancer	2.78e-05	0.000219	CcSEcCtD
Tamoxifen—Hypersensitivity—Etoposide—lung cancer	2.77e-05	0.000219	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—lung cancer	2.76e-05	0.000218	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—lung cancer	2.76e-05	0.000218	CcSEcCtD
Tamoxifen—Headache—Gemcitabine—lung cancer	2.76e-05	0.000218	CcSEcCtD
Tamoxifen—Dyspepsia—Docetaxel—lung cancer	2.75e-05	0.000217	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—lung cancer	2.75e-05	0.000217	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—lung cancer	2.75e-05	0.000217	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—lung cancer	2.73e-05	0.000216	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—lung cancer	2.73e-05	0.000215	CcSEcCtD
Tamoxifen—Decreased appetite—Docetaxel—lung cancer	2.72e-05	0.000214	CcSEcCtD
Tamoxifen—Hypersensitivity—Paclitaxel—lung cancer	2.72e-05	0.000214	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—lung cancer	2.71e-05	0.000213	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—lung cancer	2.7e-05	0.000213	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Docetaxel—lung cancer	2.7e-05	0.000213	CcSEcCtD
Tamoxifen—Asthenia—Etoposide—lung cancer	2.7e-05	0.000213	CcSEcCtD
Tamoxifen—Fatigue—Docetaxel—lung cancer	2.7e-05	0.000213	CcSEcCtD
Tamoxifen—Nausea—Irinotecan—lung cancer	2.69e-05	0.000212	CcSEcCtD
Tamoxifen—Constipation—Docetaxel—lung cancer	2.67e-05	0.000211	CcSEcCtD
Tamoxifen—Pain—Docetaxel—lung cancer	2.67e-05	0.000211	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—lung cancer	2.67e-05	0.000211	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—lung cancer	2.66e-05	0.00021	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—lung cancer	2.65e-05	0.000209	CcSEcCtD
Tamoxifen—Asthenia—Paclitaxel—lung cancer	2.65e-05	0.000209	CcSEcCtD
Tamoxifen—Nausea—Gemcitabine—lung cancer	2.62e-05	0.000206	CcSEcCtD
Tamoxifen—Vomiting—Cisplatin—lung cancer	2.61e-05	0.000206	CcSEcCtD
Tamoxifen—Pruritus—Paclitaxel—lung cancer	2.61e-05	0.000206	CcSEcCtD
Tamoxifen—Methadone—ABCB1—lung cancer	2.6e-05	0.0109	CrCbGaD
Tamoxifen—Erythema multiforme—Doxorubicin—lung cancer	2.6e-05	0.000205	CcSEcCtD
Tamoxifen—Rash—Cisplatin—lung cancer	2.59e-05	0.000204	CcSEcCtD
Tamoxifen—Dermatitis—Cisplatin—lung cancer	2.59e-05	0.000204	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—lung cancer	2.58e-05	0.000203	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Docetaxel—lung cancer	2.56e-05	0.000202	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—lung cancer	2.55e-05	0.000201	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—lung cancer	2.55e-05	0.000201	CcSEcCtD
Tamoxifen—Diarrhoea—Paclitaxel—lung cancer	2.52e-05	0.000199	CcSEcCtD
Tamoxifen—Dizziness—Etoposide—lung cancer	2.49e-05	0.000196	CcSEcCtD
Tamoxifen—Abdominal pain—Docetaxel—lung cancer	2.47e-05	0.000195	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—lung cancer	2.47e-05	0.000195	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—lung cancer	2.45e-05	0.000194	CcSEcCtD
Tamoxifen—Dizziness—Paclitaxel—lung cancer	2.44e-05	0.000192	CcSEcCtD
Tamoxifen—Nausea—Cisplatin—lung cancer	2.44e-05	0.000192	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—lung cancer	2.43e-05	0.000191	CcSEcCtD
Tamoxifen—Cough—Methotrexate—lung cancer	2.41e-05	0.00019	CcSEcCtD
Tamoxifen—Vomiting—Etoposide—lung cancer	2.39e-05	0.000189	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—lung cancer	2.39e-05	0.000189	CcSEcCtD
Tamoxifen—Rash—Etoposide—lung cancer	2.37e-05	0.000187	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—lung cancer	2.37e-05	0.000187	CcSEcCtD
Tamoxifen—Headache—Etoposide—lung cancer	2.36e-05	0.000186	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—lung cancer	2.35e-05	0.000185	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—lung cancer	2.35e-05	0.000185	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—lung cancer	2.35e-05	0.000185	CcSEcCtD
Tamoxifen—Vomiting—Paclitaxel—lung cancer	2.35e-05	0.000185	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—lung cancer	2.34e-05	0.000185	CcSEcCtD
Tamoxifen—Rash—Paclitaxel—lung cancer	2.33e-05	0.000184	CcSEcCtD
Tamoxifen—Dermatitis—Paclitaxel—lung cancer	2.32e-05	0.000183	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—lung cancer	2.32e-05	0.000183	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—lung cancer	2.31e-05	0.000182	CcSEcCtD
Tamoxifen—Headache—Paclitaxel—lung cancer	2.31e-05	0.000182	CcSEcCtD
Tamoxifen—Hypersensitivity—Docetaxel—lung cancer	2.3e-05	0.000182	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—lung cancer	2.3e-05	0.000181	CcSEcCtD
Tamoxifen—Asthenia—Docetaxel—lung cancer	2.24e-05	0.000177	CcSEcCtD
Tamoxifen—Infection—Methotrexate—lung cancer	2.24e-05	0.000177	CcSEcCtD
Tamoxifen—Nausea—Etoposide—lung cancer	2.24e-05	0.000176	CcSEcCtD
Tamoxifen—Pruritus—Docetaxel—lung cancer	2.21e-05	0.000175	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—lung cancer	2.21e-05	0.000174	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—lung cancer	2.21e-05	0.000174	CcSEcCtD
Tamoxifen—Nausea—Paclitaxel—lung cancer	2.19e-05	0.000173	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—lung cancer	2.18e-05	0.000172	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—lung cancer	2.15e-05	0.000169	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—lung cancer	2.14e-05	0.000169	CcSEcCtD
Tamoxifen—Diarrhoea—Docetaxel—lung cancer	2.14e-05	0.000169	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—lung cancer	2.09e-05	0.000165	CcSEcCtD
Tamoxifen—Dizziness—Docetaxel—lung cancer	2.07e-05	0.000163	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—lung cancer	2.07e-05	0.000163	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—lung cancer	2.05e-05	0.000162	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—lung cancer	2.04e-05	0.000161	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—lung cancer	2.04e-05	0.000161	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—lung cancer	2.04e-05	0.000161	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—lung cancer	2.04e-05	0.000161	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—lung cancer	2.03e-05	0.00016	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—lung cancer	2.02e-05	0.00016	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—lung cancer	2.01e-05	0.000159	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—lung cancer	2.01e-05	0.000159	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—lung cancer	1.99e-05	0.000157	CcSEcCtD
Tamoxifen—Vomiting—Docetaxel—lung cancer	1.99e-05	0.000157	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—lung cancer	1.98e-05	0.000157	CcSEcCtD
Tamoxifen—Rash—Docetaxel—lung cancer	1.97e-05	0.000156	CcSEcCtD
Tamoxifen—Dermatitis—Docetaxel—lung cancer	1.97e-05	0.000155	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—lung cancer	1.96e-05	0.000155	CcSEcCtD
Tamoxifen—Headache—Docetaxel—lung cancer	1.96e-05	0.000155	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—lung cancer	1.95e-05	0.000154	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—lung cancer	1.95e-05	0.000154	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—lung cancer	1.94e-05	0.000153	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—lung cancer	1.94e-05	0.000153	CcSEcCtD
Tamoxifen—Pain—Methotrexate—lung cancer	1.93e-05	0.000152	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—lung cancer	1.91e-05	0.000151	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—lung cancer	1.89e-05	0.000149	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—lung cancer	1.86e-05	0.000147	CcSEcCtD
Tamoxifen—Nausea—Docetaxel—lung cancer	1.86e-05	0.000147	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—lung cancer	1.84e-05	0.000145	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—lung cancer	1.79e-05	0.000141	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—lung cancer	1.78e-05	0.000141	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.78e-05	0.00014	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—lung cancer	1.77e-05	0.000139	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—lung cancer	1.75e-05	0.000138	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—lung cancer	1.74e-05	0.000137	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—lung cancer	1.72e-05	0.000136	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—lung cancer	1.7e-05	0.000134	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—lung cancer	1.69e-05	0.000133	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—lung cancer	1.68e-05	0.000133	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—lung cancer	1.67e-05	0.000132	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—lung cancer	1.67e-05	0.000132	CcSEcCtD
Tamoxifen—Hypersensitivity—Methotrexate—lung cancer	1.66e-05	0.000131	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—lung cancer	1.62e-05	0.000128	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—lung cancer	1.6e-05	0.000126	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—lung cancer	1.59e-05	0.000126	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—lung cancer	1.55e-05	0.000122	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—lung cancer	1.54e-05	0.000122	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—lung cancer	1.54e-05	0.000122	CcSEcCtD
Tamoxifen—Dizziness—Methotrexate—lung cancer	1.49e-05	0.000118	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—lung cancer	1.44e-05	0.000113	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—lung cancer	1.43e-05	0.000113	CcSEcCtD
Tamoxifen—Rash—Methotrexate—lung cancer	1.42e-05	0.000112	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—lung cancer	1.42e-05	0.000112	CcSEcCtD
Tamoxifen—Headache—Methotrexate—lung cancer	1.41e-05	0.000111	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—lung cancer	1.4e-05	0.00011	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—lung cancer	1.38e-05	0.000109	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—lung cancer	1.34e-05	0.000106	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—lung cancer	1.34e-05	0.000105	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—lung cancer	1.29e-05	0.000102	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—lung cancer	1.24e-05	9.79e-05	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—lung cancer	1.23e-05	9.71e-05	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—lung cancer	1.23e-05	9.7e-05	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—lung cancer	1.22e-05	9.65e-05	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—lung cancer	1.16e-05	9.15e-05	CcSEcCtD
Tamoxifen—CYP3A4—Metabolism—NCOA3—lung cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CB—lung cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—lung cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NQO1—lung cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAP2K1—lung cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTEN—lung cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TYMS—lung cancer	1.25e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—lung cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CD—lung cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—lung cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MAPK3—lung cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOA1—lung cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADCY1—lung cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCG2—lung cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—lung cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TYMS—lung cancer	1.22e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—lung cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—lung cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—lung cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAT—lung cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—lung cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HPGDS—lung cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—lung cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—EP300—lung cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAT—lung cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—lung cancer	1.18e-06	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—lung cancer	1.18e-06	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.18e-06	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.17e-06	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1A1—lung cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—lung cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—lung cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—lung cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ERCC2—lung cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—lung cancer	1.16e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—POMC—lung cancer	1.15e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2A6—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCLC—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TYMS—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—EP300—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1A1—lung cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—lung cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TYMS—lung cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—lung cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ERCC2—lung cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—STK11—lung cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—POMC—lung cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—POMC—lung cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—lung cancer	1.12e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOA1—lung cancer	1.12e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CREBBP—lung cancer	1.12e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—lung cancer	1.12e-06	1.16e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—lung cancer	1.11e-06	1.15e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RAF1—lung cancer	1.11e-06	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CREBBP—lung cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CREBBP—lung cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—lung cancer	1.09e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—lung cancer	1.09e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO1—lung cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—lung cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—lung cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTOR—lung cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.07e-06	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1A1—lung cancer	1.07e-06	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ERCC2—lung cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1A1—lung cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—lung cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—POMC—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ERCC2—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—lung cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—EP300—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CREBBP—lung cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—EP300—lung cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—lung cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—lung cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—lung cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAT—lung cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.01e-06	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOA1—lung cancer	1e-06	1.04e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—lung cancer	9.94e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—lung cancer	9.93e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—lung cancer	9.92e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—lung cancer	9.88e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—lung cancer	9.82e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOA1—lung cancer	9.77e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2E1—lung cancer	9.77e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—POMC—lung cancer	9.75e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TYMS—lung cancer	9.7e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—lung cancer	9.69e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—lung cancer	9.67e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NQO1—lung cancer	9.66e-07	1e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JUN—lung cancer	9.65e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—lung cancer	9.59e-07	9.97e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.59e-07	9.96e-06	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—lung cancer	9.53e-07	9.9e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CREBBP—lung cancer	9.49e-07	9.87e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—EP300—lung cancer	9.47e-07	9.84e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—lung cancer	9.39e-07	9.76e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1A—lung cancer	9.36e-07	9.72e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—lung cancer	9.34e-07	9.7e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—lung cancer	9.27e-07	9.63e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOA1—lung cancer	9.21e-07	9.57e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—lung cancer	9.18e-07	9.54e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—lung cancer	9.14e-07	9.5e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOA1—lung cancer	9.13e-07	9.49e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1A1—lung cancer	9.09e-07	9.45e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—lung cancer	9.08e-07	9.43e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—lung cancer	9.06e-07	9.41e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ERCC2—lung cancer	9.02e-07	9.37e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—lung cancer	9e-07	9.36e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—lung cancer	8.99e-07	9.35e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—lung cancer	8.98e-07	9.33e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—lung cancer	8.92e-07	9.27e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EP300—lung cancer	8.9e-07	9.25e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—lung cancer	8.89e-07	9.24e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—lung cancer	8.8e-07	9.14e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.74e-07	9.08e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—STK11—lung cancer	8.71e-07	9.05e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—POMC—lung cancer	8.7e-07	9.04e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—lung cancer	8.66e-07	9e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—lung cancer	8.56e-07	8.89e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—POMC—lung cancer	8.49e-07	8.83e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—lung cancer	8.48e-07	8.81e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CREBBP—lung cancer	8.47e-07	8.81e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—lung cancer	8.47e-07	8.8e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—lung cancer	8.43e-07	8.76e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—lung cancer	8.41e-07	8.74e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—lung cancer	8.35e-07	8.68e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—lung cancer	8.33e-07	8.66e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—lung cancer	8.33e-07	8.66e-06	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—lung cancer	8.27e-07	8.6e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CREBBP—lung cancer	8.27e-07	8.6e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—lung cancer	8.06e-07	8.37e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—lung cancer	8.04e-07	8.35e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—lung cancer	8.01e-07	8.32e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—POMC—lung cancer	8e-07	8.32e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK3—lung cancer	7.98e-07	8.29e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—POMC—lung cancer	7.93e-07	8.24e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—lung cancer	7.93e-07	8.24e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—lung cancer	7.85e-07	8.15e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—lung cancer	7.84e-07	8.15e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—lung cancer	7.84e-07	8.15e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAT—lung cancer	7.84e-07	8.15e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—lung cancer	7.83e-07	8.14e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOA1—lung cancer	7.8e-07	8.11e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CREBBP—lung cancer	7.79e-07	8.1e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—lung cancer	7.77e-07	8.08e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—lung cancer	7.76e-07	8.06e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—lung cancer	7.74e-07	8.05e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CREBBP—lung cancer	7.73e-07	8.03e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—lung cancer	7.71e-07	8.01e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—lung cancer	7.64e-07	7.94e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—EP300—lung cancer	7.64e-07	7.94e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—lung cancer	7.63e-07	7.92e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—lung cancer	7.59e-07	7.89e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TYMS—lung cancer	7.49e-07	7.78e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—EP300—lung cancer	7.48e-07	7.77e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.47e-07	7.76e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—EP300—lung cancer	7.47e-07	7.76e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—lung cancer	7.4e-07	7.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—lung cancer	7.4e-07	7.69e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—lung cancer	7.39e-07	7.68e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—lung cancer	7.33e-07	7.61e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—lung cancer	7.3e-07	7.58e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—lung cancer	7.23e-07	7.52e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—lung cancer	7.19e-07	7.47e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—lung cancer	7.17e-07	7.45e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—lung cancer	7.12e-07	7.4e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—EP300—lung cancer	7.05e-07	7.33e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A1—lung cancer	7.02e-07	7.29e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—lung cancer	7e-07	7.28e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—lung cancer	7e-07	7.28e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ERCC2—lung cancer	6.96e-07	7.23e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—lung cancer	6.94e-07	7.21e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—lung cancer	6.92e-07	7.19e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—lung cancer	6.84e-07	7.1e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—lung cancer	6.78e-07	7.05e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—POMC—lung cancer	6.78e-07	7.05e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—lung cancer	6.77e-07	7.04e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CREBBP—lung cancer	6.6e-07	6.86e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—lung cancer	6.59e-07	6.84e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—EP300—lung cancer	6.47e-07	6.72e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—lung cancer	6.44e-07	6.69e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—lung cancer	6.39e-07	6.64e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—lung cancer	6.38e-07	6.63e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—lung cancer	6.37e-07	6.62e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—lung cancer	6.33e-07	6.58e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—lung cancer	6.3e-07	6.54e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—lung cancer	6.26e-07	6.51e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—lung cancer	6.24e-07	6.49e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—lung cancer	6.18e-07	6.42e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—lung cancer	6.09e-07	6.33e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—lung cancer	6.05e-07	6.29e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOA1—lung cancer	6.02e-07	6.26e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—lung cancer	5.91e-07	6.14e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—lung cancer	5.83e-07	6.06e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—EP300—lung cancer	5.77e-07	6e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—lung cancer	5.72e-07	5.94e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—lung cancer	5.65e-07	5.87e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—EP300—lung cancer	5.63e-07	5.85e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—lung cancer	5.57e-07	5.78e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—lung cancer	5.53e-07	5.75e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—lung cancer	5.52e-07	5.74e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—lung cancer	5.52e-07	5.73e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—lung cancer	5.5e-07	5.71e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—lung cancer	5.46e-07	5.67e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—lung cancer	5.41e-07	5.62e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—lung cancer	5.38e-07	5.59e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—EP300—lung cancer	5.31e-07	5.52e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—EP300—lung cancer	5.26e-07	5.47e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—POMC—lung cancer	5.23e-07	5.44e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—lung cancer	5.22e-07	5.42e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CREBBP—lung cancer	5.1e-07	5.3e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—lung cancer	4.83e-07	5.02e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—lung cancer	4.78e-07	4.97e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—lung cancer	4.77e-07	4.96e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—lung cancer	4.72e-07	4.9e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—lung cancer	4.62e-07	4.8e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—lung cancer	4.52e-07	4.7e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—lung cancer	4.51e-07	4.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—EP300—lung cancer	4.5e-07	4.67e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—lung cancer	4.27e-07	4.44e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—lung cancer	4.26e-07	4.43e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—lung cancer	4.21e-07	4.38e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—lung cancer	4.17e-07	4.34e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—lung cancer	4.17e-07	4.33e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—lung cancer	3.93e-07	4.08e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—lung cancer	3.91e-07	4.06e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—lung cancer	3.89e-07	4.05e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—lung cancer	3.64e-07	3.78e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—lung cancer	3.49e-07	3.62e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—EP300—lung cancer	3.47e-07	3.61e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—lung cancer	3.4e-07	3.54e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—lung cancer	3.33e-07	3.46e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—lung cancer	3.21e-07	3.33e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—lung cancer	3.18e-07	3.3e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—lung cancer	2.72e-07	2.82e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—lung cancer	2.57e-07	2.67e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—lung cancer	2.1e-07	2.18e-06	CbGpPWpGaD
